Do analysts prefer XAIR or TMDIF?

Beyond Air currently has a consensus price target of $200.00, indicating a potential upside of 3,064.56%. Given Beyond Air's stronger consensus rating and higher possible upside, research analysts clearly believe Beyond Air is more favorable than Titan Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beyond Air 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable valuation & earnings, XAIR or TMDIF?

Titan Medical has higher revenue and earnings than Beyond Air. Beyond Air is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Beyond Air $7.68M 0.59 -$33.25M -$88.00 N/A Titan Medical $17.63M 0.95 $6.95M $0.05 2.93

Is XAIR or TMDIF more profitable?

Titan Medical has a net margin of 0.00% compared to Beyond Air's net margin of -435.71%. Titan Medical's return on equity of -82.31% beat Beyond Air's return on equity. Company Net Margins Return on Equity Return on Assets Beyond Air -435.71% -364.17% -97.43% Titan Medical N/A -82.31% -51.47%

Does the media refer more to XAIR or NMTC?

In the previous week, Beyond Air had 3 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 8 mentions for Beyond Air and 5 mentions for NeuroOne Medical Technologies. NeuroOne Medical Technologies' average media sentiment score of 0.77 beat Beyond Air's score of 0.11 indicating that NeuroOne Medical Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beyond Air 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NeuroOne Medical Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend XAIR or ZJYL?

Beyond Air currently has a consensus price target of $200.00, suggesting a potential upside of 3,064.56%. Given Beyond Air's stronger consensus rating and higher probable upside, equities analysts plainly believe Beyond Air is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beyond Air 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, XAIR or ZJYL?

Jin Medical International has higher revenue and earnings than Beyond Air. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Beyond Air $7.68M 0.59 -$33.25M -$88.00 N/A Jin Medical International $20.69M 12.81 $1.19M N/A N/A

Does the media refer more to XAIR or ZJYL?

In the previous week, Beyond Air had 5 more articles in the media than Jin Medical International. MarketBeat recorded 8 mentions for Beyond Air and 3 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 1.12 beat Beyond Air's score of 0.11 indicating that Jin Medical International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beyond Air 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Jin Medical International 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, XAIR or IRIX?

IRIDEX has higher revenue and earnings than Beyond Air. IRIDEX is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Beyond Air $7.68M 0.59 -$33.25M -$88.00 N/A IRIDEX $52.67M 0.28 -$4.44M -$0.19 N/A

Is XAIR or IRIX more profitable?

IRIDEX has a net margin of -6.23% compared to Beyond Air's net margin of -435.71%. IRIDEX's return on equity of 0.00% beat Beyond Air's return on equity. Company Net Margins Return on Equity Return on Assets Beyond Air -435.71% -364.17% -97.43% IRIDEX -6.23% N/A -11.16%

Is ADGM or XAIR more profitable?

Adagio Medical has a net margin of 0.00% compared to Beyond Air's net margin of -435.71%. Beyond Air's return on equity of -364.17% beat Adagio Medical's return on equity. Company Net Margins Return on Equity Return on Assets Adagio Medical N/A -661.85% -73.35% Beyond Air -435.71% -364.17% -97.43%

Does the media prefer ADGM or XAIR?

In the previous week, Beyond Air had 4 more articles in the media than Adagio Medical. MarketBeat recorded 8 mentions for Beyond Air and 4 mentions for Adagio Medical. Beyond Air's average media sentiment score of 0.11 beat Adagio Medical's score of -0.28 indicating that Beyond Air is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adagio Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Beyond Air 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Beyond Air (XAIR) Competitors

$6.32 -0.60 (-8.67%)

Closing price 04:00 PM Eastern

Extended Trading

$6.32 0.00 (0.00%)

As of 07:34 PM Eastern

Compare

XAIR vs. TMDIF, NMTC, ZJYL, IRIX, and ADGM

Should you buy Beyond Air stock or one of its competitors? Beyond Air's main competitors and comparable companies include Titan Medical (TMDIF), NeuroOne Medical Technologies (NMTC), Jin Medical International (ZJYL), IRIDEX (IRIX), and Adagio Medical (ADGM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Beyond Air compare to Titan Medical?

Beyond Air (NASDAQ:XAIR) and Titan Medical (NASDAQ:TMDIF) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, profitability, dividends, valuation and analyst recommendations.

Titan Medical has a net margin of 0.00% compared to Beyond Air's net margin of -435.71%. Titan Medical's return on equity of -82.31% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-435.71%	-364.17%	-97.43%
Titan Medical	N/A	-82.31%	-51.47%

In the previous week, Beyond Air had 8 more articles in the media than Titan Medical. MarketBeat recorded 8 mentions for Beyond Air and 0 mentions for Titan Medical. Beyond Air's average media sentiment score of 0.11 beat Titan Medical's score of 0.00 indicating that Beyond Air is being referred to more favorably in the media.

Company	Overall Sentiment
Beyond Air	Neutral
Titan Medical	Neutral

Beyond Air has a beta of 0.23, indicating that its share price is 77% less volatile than the broader market. Comparatively, Titan Medical has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

Titan Medical has higher revenue and earnings than Beyond Air. Beyond Air is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$7.68M	0.59	-$33.25M	-$88.00	N/A
Titan Medical	$17.63M	0.95	$6.95M	$0.05	2.93

31.5% of Beyond Air shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 10.0% of Beyond Air shares are owned by company insiders. Comparatively, 0.0% of Titan Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Beyond Air currently has a consensus price target of $200.00, indicating a potential upside of 3,064.56%. Given Beyond Air's stronger consensus rating and higher possible upside, research analysts clearly believe Beyond Air is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Beyond Air and Titan Medical tied by winning 8 of the 16 factors compared between the two stocks.

How does Beyond Air compare to NeuroOne Medical Technologies?

Beyond Air (NASDAQ:XAIR) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and media sentiment.

NeuroOne Medical Technologies has higher revenue and earnings than Beyond Air. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$7.68M	0.59	-$33.25M	-$88.00	N/A
NeuroOne Medical Technologies	$12.10M	1.39	-$3.61M	-$0.85	N/A

31.5% of Beyond Air shares are held by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are held by institutional investors. 10.0% of Beyond Air shares are held by insiders. Comparatively, 11.8% of NeuroOne Medical Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

NeuroOne Medical Technologies has a net margin of -71.50% compared to Beyond Air's net margin of -435.71%. NeuroOne Medical Technologies' return on equity of -115.61% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-435.71%	-364.17%	-97.43%
NeuroOne Medical Technologies	-71.50%	-115.61%	-79.63%

In the previous week, Beyond Air had 3 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 8 mentions for Beyond Air and 5 mentions for NeuroOne Medical Technologies. NeuroOne Medical Technologies' average media sentiment score of 0.77 beat Beyond Air's score of 0.11 indicating that NeuroOne Medical Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beyond Air	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
NeuroOne Medical Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Beyond Air currently has a consensus target price of $200.00, suggesting a potential upside of 3,064.56%. NeuroOne Medical Technologies has a consensus target price of $7.33, suggesting a potential upside of 278.01%. Given Beyond Air's higher possible upside, equities analysts plainly believe Beyond Air is more favorable than NeuroOne Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
NeuroOne Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Beyond Air has a beta of 0.23, suggesting that its stock price is 77% less volatile than the broader market. Comparatively, NeuroOne Medical Technologies has a beta of 0.61, suggesting that its stock price is 39% less volatile than the broader market.

Summary

NeuroOne Medical Technologies beats Beyond Air on 12 of the 16 factors compared between the two stocks.

How does Beyond Air compare to Jin Medical International?

Beyond Air (NASDAQ:XAIR) and Jin Medical International (NASDAQ:ZJYL) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.

In the previous week, Beyond Air had 5 more articles in the media than Jin Medical International. MarketBeat recorded 8 mentions for Beyond Air and 3 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 1.12 beat Beyond Air's score of 0.11 indicating that Jin Medical International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beyond Air	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Jin Medical International	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Jin Medical International has a net margin of 0.00% compared to Beyond Air's net margin of -435.71%. Jin Medical International's return on equity of 0.00% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-435.71%	-364.17%	-97.43%
Jin Medical International	N/A	N/A	N/A

Beyond Air currently has a consensus price target of $200.00, suggesting a potential upside of 3,064.56%. Given Beyond Air's stronger consensus rating and higher probable upside, equities analysts plainly believe Beyond Air is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

31.5% of Beyond Air shares are held by institutional investors. 10.0% of Beyond Air shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Beyond Air has a beta of 0.23, meaning that its share price is 77% less volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.34, meaning that its share price is 634% more volatile than the broader market.

Jin Medical International has higher revenue and earnings than Beyond Air.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$7.68M	0.59	-$33.25M	-$88.00	N/A
Jin Medical International	$20.69M	12.81	$1.19M	N/A	N/A

Summary

Jin Medical International beats Beyond Air on 8 of the 14 factors compared between the two stocks.

How does Beyond Air compare to IRIDEX?

Beyond Air (NASDAQ:XAIR) and IRIDEX (NASDAQ:IRIX) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, risk, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability.

IRIDEX has a net margin of -6.23% compared to Beyond Air's net margin of -435.71%. IRIDEX's return on equity of 0.00% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-435.71%	-364.17%	-97.43%
IRIDEX	-6.23%	N/A	-11.16%

31.5% of Beyond Air shares are held by institutional investors. Comparatively, 20.1% of IRIDEX shares are held by institutional investors. 10.0% of Beyond Air shares are held by insiders. Comparatively, 8.6% of IRIDEX shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

IRIDEX has higher revenue and earnings than Beyond Air. IRIDEX is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$7.68M	0.59	-$33.25M	-$88.00	N/A
IRIDEX	$52.67M	0.28	-$4.44M	-$0.19	N/A

Beyond Air has a beta of 0.23, indicating that its stock price is 77% less volatile than the broader market. Comparatively, IRIDEX has a beta of 0.66, indicating that its stock price is 34% less volatile than the broader market.

Beyond Air currently has a consensus price target of $200.00, suggesting a potential upside of 3,064.56%. IRIDEX has a consensus price target of $3.00, suggesting a potential upside of 250.47%. Given Beyond Air's stronger consensus rating and higher probable upside, equities analysts plainly believe Beyond Air is more favorable than IRIDEX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Beyond Air had 7 more articles in the media than IRIDEX. MarketBeat recorded 8 mentions for Beyond Air and 1 mentions for IRIDEX. IRIDEX's average media sentiment score of 1.89 beat Beyond Air's score of 0.11 indicating that IRIDEX is being referred to more favorably in the news media.

Company	Overall Sentiment
Beyond Air	Neutral
IRIDEX	Very Positive

Summary

Beyond Air and IRIDEX tied by winning 8 of the 16 factors compared between the two stocks.

How does Beyond Air compare to Adagio Medical?

Adagio Medical (NASDAQ:ADGM) and Beyond Air (NASDAQ:XAIR) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, media sentiment, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation.

Adagio Medical presently has a consensus price target of $3.50, indicating a potential upside of 405.63%. Beyond Air has a consensus price target of $200.00, indicating a potential upside of 3,064.56%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts plainly believe Beyond Air is more favorable than Adagio Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Adagio Medical has a beta of -0.15, suggesting that its share price is 115% less volatile than the broader market. Comparatively, Beyond Air has a beta of 0.23, suggesting that its share price is 77% less volatile than the broader market.

48.1% of Adagio Medical shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 7.8% of Adagio Medical shares are owned by insiders. Comparatively, 10.0% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Beyond Air had 4 more articles in the media than Adagio Medical. MarketBeat recorded 8 mentions for Beyond Air and 4 mentions for Adagio Medical. Beyond Air's average media sentiment score of 0.11 beat Adagio Medical's score of -0.28 indicating that Beyond Air is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Adagio Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Beyond Air	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Adagio Medical has higher earnings, but lower revenue than Beyond Air. Adagio Medical is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adagio Medical	$600K	25.62	-$25.08M	-$1.53	N/A
Beyond Air	$7.68M	0.59	-$33.25M	-$88.00	N/A

Adagio Medical has a net margin of 0.00% compared to Beyond Air's net margin of -435.71%. Beyond Air's return on equity of -364.17% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	-661.85%	-73.35%
Beyond Air	-435.71%	-364.17%	-97.43%

Summary

Beyond Air beats Adagio Medical on 9 of the 15 factors compared between the two stocks.

Get Beyond Air News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XAIR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XAIR vs. The Competition

Export

Metric	Beyond Air	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$4.99M	$5.95B	$7.06B	$13.10B
Dividend Yield	N/A	1.76%	2.57%	10.45%
P/E Ratio	-0.09	26.22	269.06	25.28
Price / Sales	0.59	63.09	602.43	91.76
Price / Cash	N/A	33.92	70.48	50.90
Price / Book	0.67	6.10	12.91	6.24
Net Income	-$33.25M	$148.67M	$3.45B	$347.60M
7 Day Performance	17.91%	1.84%	1.12%	1.07%
1 Month Performance	9.53%	4.56%	1.79%	1.03%
1 Year Performance	-86.38%	8.67%	67.69%	20.77%

Beyond Air Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XAIR Beyond Air	3.3677 of 5 stars	$6.32 -8.7%	$200.00 +3,064.6%	-85.9%	$4.99M	$7.68M	N/A	70	News Coverage Earnings Report
TMDIF Titan Medical	N/A	$0.14 +5.7%	N/A	-61.9%	$16.30M	$17.63M	N/A	50	Gap Down
NMTC NeuroOne Medical Technologies	2.5881 of 5 stars	$1.75 +3.6%	$11.67 +566.7%	-64.5%	$15.23M	$12.10M	N/A	20	News Coverage Earnings Report Analyst Forecast Short Interest Increase Gap Up
ZJYL Jin Medical International	1.3236 of 5 stars	$2.19 +12.9%	N/A	-74.9%	$14.96M	$20.69M	N/A	245	Positive News Short Interest Decrease High Trading Volume
IRIX IRIDEX	2.6177 of 5 stars	$0.81 -0.8%	$3.00 +268.6%	-30.2%	$14.17M	$52.67M	N/A	120	Positive News Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XAIR) was last updated on 8/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Beyond Air (XAIR) Competitors

XAIR vs. TMDIF, NMTC, ZJYL, IRIX, and ADGM

How does Beyond Air compare to Titan Medical?

Summary

How does Beyond Air compare to NeuroOne Medical Technologies?

Summary

How does Beyond Air compare to Jin Medical International?

Summary

How does Beyond Air compare to IRIDEX?

Summary

How does Beyond Air compare to Adagio Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XAIR vs. The Competition

Beyond Air Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Beyond Air (XAIR) Competitors

XAIR vs. TMDIF, NMTC, ZJYL, IRIX, and ADGM

How does Beyond Air compare to Titan Medical?

Is XAIR or TMDIF more profitable?

Does the media refer more to XAIR or TMDIF?

Which has more volatility & risk, XAIR or TMDIF?

Which has preferable valuation & earnings, XAIR or TMDIF?

Do institutionals and insiders believe in XAIR or TMDIF?

Do analysts prefer XAIR or TMDIF?

Summary

How does Beyond Air compare to NeuroOne Medical Technologies?

Which has better earnings and valuation, XAIR or NMTC?

Do institutionals and insiders hold more shares of XAIR or NMTC?

Is XAIR or NMTC more profitable?

Does the media refer more to XAIR or NMTC?

Do analysts prefer XAIR or NMTC?

Which has more volatility & risk, XAIR or NMTC?

Summary

How does Beyond Air compare to Jin Medical International?

Does the media refer more to XAIR or ZJYL?

Is XAIR or ZJYL more profitable?

Do analysts recommend XAIR or ZJYL?

Do insiders and institutionals have more ownership in XAIR or ZJYL?

Which has more risk & volatility, XAIR or ZJYL?

Which has higher valuation & earnings, XAIR or ZJYL?

Summary

How does Beyond Air compare to IRIDEX?

Is XAIR or IRIX more profitable?

Do institutionals and insiders believe in XAIR or IRIX?

Which has higher earnings and valuation, XAIR or IRIX?

Which has more risk & volatility, XAIR or IRIX?

Do analysts rate XAIR or IRIX?

Does the media favor XAIR or IRIX?

Summary

How does Beyond Air compare to Adagio Medical?

Do analysts recommend ADGM or XAIR?

Which has more volatility and risk, ADGM or XAIR?

Do institutionals and insiders believe in ADGM or XAIR?

Does the media prefer ADGM or XAIR?

Which has preferable valuation and earnings, ADGM or XAIR?

Is ADGM or XAIR more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XAIR vs. The Competition

Beyond Air Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools